LNTH Lantheus Holdings, Inc.
Lantheus Holdings, Inc. (LNTH) is expected to report earnings on November 5, 2026, before the market open. The consensus earnings estimate is $1.09 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -0.6% since its last earnings release on August 6, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Lantheus Holdings, Inc.
Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB and an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find Fight and Follow® serious medical conditions.
Sector
Healthcare
Industry
Diagnostic Substances